R. K. Boeckman Jr. et al. / Tetrahedron Letters 52 (2011) 2243–2245
2245
O
References and notes
HOOC
N
TMS
O
TMS
N
1. Mata, J. E.; Dyal, L. A.; Slauson, M. E.; Summerton, J. E.; Loehr, C.; Tyson, A. R.;
Rodriguez-Proteau, R.; Gustafson, S. B. Nanomed. Nanotechnol. Biol. Med. 2007,
3, 297–305.
2. Gerweck, L. E.; Vijayappa, S.; Kozin, S. Mol. Cancer Ther. 2006, 5, 1275–1279.
3. Gerweck, L. E.; Kozin, S. V. Cancer Res. 1996, 56, 1194–1198.
4. Wike-Hooley, J. L.; Haverman, J.; Reinhold, H. S. Radiother. Oncol. 1997, 2, 343–
366.
TMS
TBAF
THF
H2O2/H2O
5
N
N
COOH
O
TMS
O
6
19
5. Gerweck, L. E. Semin. Radiat. Oncol. 1998, 8, 176–182.
Scheme 5. Synthesis of bis N-oxides 5.
6. Ginos, J. Z.; Tilbury, R. S.; Haber, M. T.; Rottenberg, D. A. J. Nucl. Med. 1982, 23,
255–258.
7. Rottenberg, D. A.; Ginos, J. Z.; Kearfott, K. G.; Junck, L.; Dhawan, V.; Jarden, J. O.
Ann. Neurol. 1985, 17, 70–79.
Literature precedent suggested that N-oxides can be formed
with mCPBA/K2CO3 at À78 °C under conditions where epoxidation
of the vinyl silane double bond was expected to be slow.23 To our
disappointment, 19 was either recovered unchanged at À78 °C or
resulted in formation of an uncharacterizable mixture of products
at À50 °C. Remarkably diacid 19 also proved inert to oxidation by
H2O2/CH3OH.24 However, we were pleased to find that treatment
with 50% H2O2/H2O finally afforded our target molecule 5 as a mix-
ture of diastereomers.25
Unfortunately, upon biological evaluation, the modification of
the pKas provided by the second acid/N-oxide moiety proved insuf-
ficient to render bis N-oxide 5 a viable diagnostic or treatment.
Nevertheless, the dimer 5 played a valuable role in helping to move
forward on the long quest toward possible specific and effective
acid-targeted cancer diagnostics and therapeutics by permitting
recognition of the importance of other cellular mechanisms such
as competing efflux which must be overcome to permit sufficient
sequestration and retention in the tumor cells. The delicacy with
which the molecular properties must be manipulated continues
to delineate the synthesis and design challenges facing the devel-
opment of such high-specificity acid-targeted agents.
8. Kozin, S. V.; Shkarin, P.; Gerweck, L. E. Cancer Res. 2001, 61, 4740–4743.
9. Mikkelsen, R. B.; Asher, C.; Hicks, T. Biochem. Pharmacol. 1985, 34, 2531–2534.
10. Summerton, J. E., PCT Int. Appl. WO2008121126, 2008.
11. Summerton, J. E., U.S. Pat. Appl. Publ. US2007231256, 2007.
12. Summerton, J. E., PCT Int. Appl. WO2007117398, 2007.
13. (a) Wanner, K. T. Liebigs Ann. Chem. 1988, 6, 603–604; (b) Wanner, K. T. Arch.
Pharm. (Weinheim, Ger.) 1988, 321, 353–356.
14. (a) Skotnicki, J. S.; Kearney, R. M.; Smith, A. L. Tetrahedron Lett. 1994, 35, 197–
200; (b) Albrecht, M.; Spieß, O.; Schneider, M. Synthesis 2002, 1, 126–132; (c)
Back, T. G.; Wulff, J. E. Angew. Chem., Int. Ed. 2004, 43, 6493–6496; (d) Neises,
B.; Steglich, W. Angew. Chem., Int. Ed. Engl. 1978, 17, 522–524.
15. Song, X. Ph.D. Dissertation, University of Rochester, 2006
16. Salvatore, R. N.; Nagle, A. S.; Jung, K. W. J. Org. Chem. 2002, 67, 674–683.
17. (a) Welch, C.; Archibald, S. J.; Boyle, R. W. Synthesis 2009, 4, 551–556; (b)
Menche, D.; Böhm, S.; Li, J.; Rudolph, S.; Zander, W. Tetrahedron Lett. 2007, 48,
365–369.
18. Insaf, S. S.; Witiak, D. T. Tetrahedron 2000, 56, 2359–2367.
19. (a) Le Ménez, P.; Brion, J.-D.; Lensen, N.; Chelain, E.; Pancrazi, A.; Ardisson, J.
Synthesis 2003, 16, 2530–2534; (b) Nylund, C. S.; Smith, D. T.; Klopp, J. M.;
Weinreb, S. M. Tetrahedron 1995, 51, 9301–9318.
20. Huh, N.; Thompson, C. M. Tetrahedron 1995, 51, 5935–5950.
21. Langlois, Y.; Konopski, L.; Bac, N. V.; Chiaroni, A.; Riche, C. Tetrahedron Lett.
1990, 31, 1865–1868.
22. Pignard, S.; Lopin, C.; Gouhier, G.; Piettre, S. R. J. Org. Chem. 2006, 71, 31–37.
23. (a) Huang, J.; Liu, X.; Wen, Y.; Qin, B.; Feng, X. J. Org. Chem. 2007, 72, 204–208;
(b) O’Neil, I. A.; Miller, N. D.; Peake, J.; Barkley, J. V.; Low, C. M. R.; Kalindjian, S.
B. Synlett 1993, 515–518.
24. Middlemas, E. D.; Quin, L. D. J. Org. Chem. 1979, 44, 2587–2589.
25. Hoh, G. L. K.; Barlow, D. O.; Chadwick, A. F.; Lake, D. B.; Sheeran, S. R. J. Am. Oil
Chem. Soc. 1963, 40, 268–271.
Acknowledgment
We are grateful for support of these studies by Gene Tools, LLC.
Supplementary data
Supplementary data associated with this article can be found, in